BioSentinel Pharmaceuticals
Ward Tucker is currently the Director of Research and Development at BIOSENTINEL, INC. Prior to that, they worked as a Senior Scientist at the same company. Before joining BIOSENTINEL, INC., they served as a Research Scientist at Neoclone Biotechnology. Ward also worked as a Visiting Research Scholar at the Weizmann Institute of Science. They completed their postdoctoral studies in Biochemistry/Neuroscience at the University of Wisconsin-Madison, earned a Doctor of Philosophy - PhD in Biochemistry from The University of Kansas, and obtained a Bachelor of Science - BS in Biochemistry from the same university.
This person is not in any teams
BioSentinel Pharmaceuticals
BioSentinel develops innovative tools and reagents for the study of botulinum neurotoxin (BoNT).